Some were afraid of them, but botulinum toxin injections, supposed to relax muscles and face, are well ahead in the panorama of plastic medicine. The proof : since the beginning of the new millennium, no fewer than 10 million people have been treated -each year ! The number is high enough to open the market to competitors. So far, there was Vistabel, Allergan's Botox. Since last year, the molecule has had to face the arrival of Azzalure, the new solution by Galderma & Ipsen. At the tip of the needle : botulunum toxin type A. Except that global formulas are changing : less liquid in Azzalure's, therefore less water injected each time, less pressure on the forehead muscle and fewer headaches. Galderma & Ipsen's toxin reportedly settles in 3 days and stays in place for 4 to 5 months, as opposed to 7 to 10 days for Vistabel's that stays in place for 3 or 4 months. Differences that allow clients to save one session per year and the physician to work with more precision and subtlety. The first wrinkles will rather turn to Vistabel whereas more marked skins will be able to rely on Azzalure, which will also serve to work more precisely on small muscles...
